JAMA Network
About The Study: In this study of patients enrolled in Medicare in 2022, those at the highest risk for severe COVID-19 infection received COVID-19 therapy less often than those with the least risk. Disparities in therapy access were found by patient age, race and ethnicity, Medicaid eligibility, and nursing home residence.
Authors: Michael L. Barnett, M.D., of the Harvard T.H. Chan School of Public Health in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2023.5044)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
